Your browser is no longer supported. Please, upgrade your browser.
Settings
NLTX [NASD]
Neoleukin Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.74 Insider Own8.60% Shs Outstand54.94M Perf Week-10.01%
Market Cap291.67M Forward P/E- EPS next Y-1.16 Insider Trans0.23% Shs Float32.89M Perf Month-27.87%
Income-39.60M PEG- EPS next Q-0.26 Inst Own68.20% Short Float6.26% Perf Quarter-41.36%
Sales- P/S- EPS this Y75.00% Inst Trans0.14% Short Ratio10.95 Perf Half Y-47.80%
Book/sh3.26 P/B2.04 EPS next Y-7.40% ROA-20.40% Target Price- Perf Year-34.80%
Cash/sh4.07 P/C1.63 EPS next 5Y31.10% ROE-22.60% 52W Range6.55 - 17.95 Perf YTD-52.84%
Dividend- P/FCF- EPS past 5Y18.00% ROI- 52W High-58.55% Beta0.89
Dividend %- Quick Ratio21.60 Sales past 5Y- Gross Margin- 52W Low13.59% ATR0.48
Employees70 Current Ratio21.60 Sales Q/Q- Oper. Margin- RSI (14)40.49 Volatility6.91% 5.87%
OptionableYes Debt/Eq0.00 EPS Q/Q-54.80% Profit Margin- Rel Volume0.76 Prev Close6.65
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume188.03K Price7.44
Recom1.40 SMA20-7.20% SMA50-18.98% SMA200-35.44% Volume44,906 Change11.88%
Jan-06-21Initiated Stifel Buy $18
Sep-23-20Initiated Robert W. Baird Outperform $25
Jun-18-20Initiated Mizuho Buy $21
Apr-13-20Initiated H.C. Wainwright Buy $22
Mar-16-20Initiated BofA/Merrill Buy $18
Mar-12-20Initiated Canaccord Genuity Buy $20
Feb-18-20Initiated Guggenheim Buy $20
Jan-10-20Initiated Piper Sandler Overweight $20
Jun-08-21 01:56AM  
May-26-21 08:00AM  
May-17-21 10:29AM  
May-12-21 08:00AM  
May-05-21 08:00AM  
May-04-21 08:00AM  
May-03-21 08:00AM  
Apr-26-21 10:19AM  
07:00AM  
Apr-17-21 09:20AM  
Mar-26-21 08:00PM  
Mar-25-21 04:00PM  
02:30PM  
Mar-18-21 08:00AM  
Mar-02-21 08:00AM  
Feb-05-21 08:00AM  
Jan-28-21 11:15PM  
Jan-25-21 11:56PM  
02:49PM  
Jan-23-21 11:45PM  
Jan-20-21 11:53PM  
Jan-14-21 11:25AM  
Jan-08-21 12:49PM  
08:37AM  
08:00AM  
Jan-07-21 08:00AM  
Dec-10-20 08:00AM  
Nov-23-20 08:00AM  
Nov-18-20 01:59AM  
Nov-11-20 08:00AM  
Nov-10-20 08:00AM  
Nov-09-20 08:00AM  
Nov-05-20 02:00PM  
Oct-20-20 08:00AM  
Oct-14-20 05:05PM  
Oct-13-20 03:06PM  
Sep-23-20 09:33AM  
Sep-15-20 01:11PM  
Sep-10-20 08:00AM  
Sep-09-20 08:00AM  
Aug-20-20 01:26PM  
Aug-19-20 12:00PM  
Aug-12-20 04:01PM  
Aug-06-20 08:00AM  
Aug-05-20 08:00AM  
Aug-03-20 10:50AM  
Jul-15-20 07:21AM  
Jul-07-20 07:35AM  
Jul-03-20 12:00PM  
Jul-02-20 12:54PM  
09:00AM  
Jul-01-20 04:01PM  
Jun-24-20 10:24AM  
Jun-22-20 09:05AM  
Jun-19-20 12:49PM  
Jun-15-20 08:00AM  
Jun-01-20 08:00AM  
May-27-20 08:00AM  
May-20-20 08:49AM  
May-15-20 07:00AM  
May-07-20 08:00AM  
May-06-20 04:01PM  
Apr-16-20 04:05PM  
Apr-09-20 08:00AM  
Mar-12-20 04:01PM  
02:30PM  
Mar-05-20 08:00AM  
Feb-25-20 08:00AM  
Feb-24-20 08:00AM  
Feb-06-20 08:00AM  
Jan-23-20 02:22PM  
Jan-21-20 07:22AM  
Dec-20-19 04:01PM  
Dec-17-19 10:26PM  
05:43PM  
04:38PM  
Dec-05-19 08:00AM  
Nov-26-19 08:00AM  
Nov-13-19 09:15AM  
Sep-20-19 11:28AM  
Sep-19-19 08:00AM  
Sep-05-19 04:05PM  
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walkey CarlSenior Vice PresidentJun 16Sale10.196006,1141,352,489Jun 17 09:46 PM
Walkey CarlSenior Vice PresidentJun 09Sale10.826507,0361,353,089Jun 11 04:13 PM
Walkey CarlSenior Vice PresidentJun 08Sale11.006006,6001,353,739Jun 09 05:22 PM
DRACHMAN JONATHAN GPresident and CEOJun 04Buy9.6110,00096,0822,248,686Jun 07 05:06 PM
Walkey CarlSenior Vice PresidentJun 04Sale10.006006,0001,354,339Jun 07 05:07 PM
DRACHMAN JONATHAN GPresident and CEOJun 03Buy9.4840,000379,2722,238,686Jun 07 05:06 PM
Walkey CarlSenior Vice PresidentMay 26Sale10.006006,0001,354,939May 26 07:37 PM
Walkey CarlSenior Vice PresidentMay 19Sale10.636006,3781,355,539May 21 05:24 PM
Walkey CarlSenior Vice PresidentMay 12Sale11.091,20013,3081,354,762May 12 08:53 PM
Walkey CarlSenior Vice PresidentMay 05Sale11.301,20013,5601,355,962May 06 05:28 PM
Walkey CarlSenior Vice PresidentApr 28Sale12.582,40030,1921,357,162Apr 30 05:52 PM
Walkey CarlSenior Vice PresidentApr 26Sale13.006007,8001,359,562Apr 27 07:59 PM
Walkey CarlSenior Vice PresidentApr 21Sale11.981,80021,5641,360,162Apr 22 05:11 PM
Walkey CarlSenior Vice PresidentApr 14Sale12.221,80021,9961,361,962Apr 16 07:08 PM
Walkey CarlSenior Vice PresidentApr 07Sale12.021,80021,6361,363,762Apr 08 07:06 PM
Walkey CarlSenior Vice PresidentApr 05Sale13.006007,8001,365,562Apr 06 08:37 PM
Walkey CarlSenior Vice PresidentMar 31Sale11.961,80021,5281,366,162Apr 02 05:21 PM
Walkey CarlSenior Vice PresidentMar 24Sale11.951,80021,5161,367,962Mar 24 06:48 PM
Walkey CarlSenior Vice PresidentMar 22Sale12.006007,2001,369,762Mar 24 06:48 PM
Walkey CarlSenior Vice PresidentMar 17Sale11.361,20013,6321,370,362Mar 18 08:45 PM
Ho RobertChief Financial OfficerMar 17Sale11.016,49771,55621,503Mar 18 08:44 PM
Ho RobertChief Financial OfficerMar 16Option Exercise0.0025,000028,000Mar 18 08:44 PM
Walkey CarlSenior Vice PresidentMar 10Sale11.971,80021,5401,371,562Mar 11 04:14 PM
Walkey CarlSenior Vice PresidentMar 03Sale11.871,80021,3601,373,362Mar 04 06:52 PM
Walkey CarlSenior Vice PresidentFeb 25Sale13.006007,8001,375,162Feb 25 08:17 PM
Walkey CarlSenior Vice PresidentFeb 24Sale12.141,80021,8521,375,762Feb 25 08:17 PM
Walkey CarlSenior Vice PresidentFeb 17Sale12.702,40030,4801,377,562Feb 18 04:20 PM
Walkey CarlSenior Vice PresidentFeb 10Sale14.203,00042,6001,379,962Feb 12 04:23 PM
Walkey CarlSenior Vice PresidentFeb 05Sale14.006008,4001,382,962Feb 09 04:41 PM
Walkey CarlSenior Vice PresidentFeb 03Sale13.232,40031,7521,383,562Feb 05 04:51 PM